120 related articles for article (PubMed ID: 8104684)
21. Perfluorodecanoic acid, a peroxisome proliferator, activates phospholipase C, inhibits CTP:phosphocholine cytidylyltransferase, and elevates diacylglycerol in rat liver.
Reo NV; Narayanan L; Kling KB; Adinehzadeh M
Toxicol Lett; 1996 Jul; 86(1):1-11. PubMed ID: 8685914
[TBL] [Abstract][Full Text] [Related]
22. Effect of the peroxisome proliferator perfluoro-n-decanoic acid on glucose transport in the isolated perfused rat liver.
Goecke-Flora CM; Wyman JF; Jarnot BM; Reo NV
Chem Res Toxicol; 1995; 8(1):77-81. PubMed ID: 7703370
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat.
Dragan YP; Xu XH; Goldsworthy TL; Campbell HA; Maronpot RR; Pitot HC
Carcinogenesis; 1992 Aug; 13(8):1389-95. PubMed ID: 1354083
[TBL] [Abstract][Full Text] [Related]
24. The biochemical toxicity of perfluorodecanoic acid in the mouse is different from that of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Brewster DW; Birnbaum LS
Toxicol Appl Pharmacol; 1989 Jul; 99(3):544-54. PubMed ID: 2749739
[TBL] [Abstract][Full Text] [Related]
25. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.
Sterchele PF; Sun H; Peterson RE; Vanden Heuvel JP
Arch Biochem Biophys; 1996 Feb; 326(2):281-9. PubMed ID: 8611035
[TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator perfluorodecanoic acid alters glutathione and related enzymes.
Chen LC; Tatum V; Glauert HP; Chow CK
J Biochem Mol Toxicol; 2001; 15(2):107-13. PubMed ID: 11284052
[TBL] [Abstract][Full Text] [Related]
27. Effects of peroxisome proliferators on rat liver phospholipids: sphingomyelin degradation may be involved in hepatotoxic mechanism of perfluorodecanoic acid.
Adinehzadeh M; Reo NV
Chem Res Toxicol; 1998 May; 11(5):428-40. PubMed ID: 9585473
[TBL] [Abstract][Full Text] [Related]
28. Effects of perfluorodecanoic acid on thyroid status in rats.
Van Rafelghem MJ; Inhorn SL; Peterson RE
Toxicol Appl Pharmacol; 1987 Mar; 87(3):430-9. PubMed ID: 3564018
[TBL] [Abstract][Full Text] [Related]
29. The initiation-promotion-progression model of rat hepatocarcinogenesis.
Dragan YP; Sargent L; Xu YD; Xu YH; Pitot HC
Proc Soc Exp Biol Med; 1993 Jan; 202(1):16-24. PubMed ID: 8093813
[TBL] [Abstract][Full Text] [Related]
30. Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation.
Vanden Heuvel JP
Gen Pharmacol; 1996 Oct; 27(7):1123-9. PubMed ID: 8981056
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
Rao MS; Lalwani ND; Watanabe TK; Reddy JK
Cancer Res; 1984 Mar; 44(3):1072-6. PubMed ID: 6692393
[TBL] [Abstract][Full Text] [Related]
32. Pathological and hepatic ultrastructural effects of a single dose of perfluoro-n-decanoic acid in the rat, hamster, mouse, and guinea pig.
Van Rafelghem MJ; Mattie DR; Bruner RH; Andersen ME
Fundam Appl Toxicol; 1987 Oct; 9(3):522-40. PubMed ID: 3692011
[TBL] [Abstract][Full Text] [Related]
33. Regulation of hepatic malic enzyme by perfluorodecanoic acid.
Kelling CK; Van Rafelghem MJ; Drake RL; Menahan LA; Peterson RE
J Biochem Toxicol; 1986 Sep; 1(3):23-37. PubMed ID: 3271879
[TBL] [Abstract][Full Text] [Related]
34. Effects of the peroxisome proliferator perfluoro-n-decanoic acid on hepatic gluconeogenesis and glycogenesis: a 13C NMR investigation.
Goecke CM; Jarnot BM; Reo NV
Chem Res Toxicol; 1994; 7(1):15-22. PubMed ID: 8155820
[TBL] [Abstract][Full Text] [Related]
35. Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats.
Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y
Cancer Lett; 1991 Apr; 57(1):55-60. PubMed ID: 2025879
[TBL] [Abstract][Full Text] [Related]
36. Effect of phenobarbital and the peroxisome proliferator ciprofibrate on gamma-Glutamyltranspeptidase activity and leukotriene C4 concentration in cultured rat hepatocytes.
Hong JT; Wilson MW; Glauert HP
J Biochem Toxicol; 1995 Oct; 10(5):239-243. PubMed ID: 8847705
[TBL] [Abstract][Full Text] [Related]
37. Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid.
Maher JM; Aleksunes LM; Dieter MZ; Tanaka Y; Peters JM; Manautou JE; Klaassen CD
Toxicol Sci; 2008 Dec; 106(2):319-28. PubMed ID: 18757529
[TBL] [Abstract][Full Text] [Related]
38. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.
Pitot HC; Goldsworthy TL; Moran S; Kennan W; Glauert HP; Maronpot RR; Campbell HA
Carcinogenesis; 1987 Oct; 8(10):1491-9. PubMed ID: 2888545
[TBL] [Abstract][Full Text] [Related]
39. Effects of the peroxisome proliferator di(2-ethylhexyl)phthalate on enzymes in rat liver and on carcinogen-induced liver altered foci in comparison to the promoter phenobarbital.
Maruyama H; Tanaka T; Williams GM
Toxicol Pathol; 1990; 18(2):257-67. PubMed ID: 1975953
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the promotion potential of chlorotrifluoroethylene trimer acid in male Sprague-Dawley rats.
Godin CS; Flemming CD; Drerup JM; Wall HG
Toxicol Lett; 1993 Jan; 66(1):63-72. PubMed ID: 8093986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
